Are You Interested in Starting Your Own Health Related Home Based Business? Please Click Here to Find Out How!

According to estimates there are 85,000 Alzheimer patients in our country and approximately 20,000 new cases every year. This spectacular increase is due to the increasing ageing population. Unfortunately it is still unclear precisely which ageing process forms the basis of this spectacular rise in the occurrence of the disease. VIB scientists affiliated to K.U.

More: continued here

Are You Interested in Starting Your Own Health Related Home Based Business? Please Click Here to Find Out How!

Terrell Owens, Penny Marshall, Garry Marshall, Molly Sims, Wayne Brady, Leeza Gibbons, Anthony Anderson, John Glover, Lainie Kazan, Kathy Mattea, Elisabeth Hasselbeck, Bryant Gumbel, Ahmad Rashad, and Emerson Drive have joined celebrities such as Dick Van Dyke, Vivica Fox, Olympia Dukakis, Natal

More: continued here

Are You Interested in Starting Your Own Health Related Home Based Business? Please Click Here to Find Out How!

Today’s Ministerial statement on dementia by Shona Robison MSP is warmly welcomed by Alzheimer Scotland. It confirms that the Scottish Government recognises the scale of the problem of dementia in Scotland, as highlighted by our recent report The Dementia Epidemic - where Scotland is now and the challenge ahead.

More: continued here

Are You Interested in Starting Your Own Health Related Home Based Business? Please Click Here to Find Out How!

Presbyterian Hospital/Weill Cornell Medical Center and Baxter International Inc. (NYSE: BAX) announced results of a six-month, placebo-controlled Phase II study of 24 patients treated with GAMMAGARD S/D and GAMMAGARD LIQUID [Immune Globulin Intravenous (IGIV)] for the treatment of mild-to-moderate Alzheimer’s disease today at the American Academy of Neurology (AAN) annual meeting in Chicago.

More: continued here

Are You Interested in Starting Your Own Health Related Home Based Business? Please Click Here to Find Out How!

Patients with mild to moderate Alzheimer’s disease who were treated with the experimental drug Dimebon from US drugmaker Medivation Inc, showed improvement in key mental skills after a year compared to patients who took the placebo. The patients on the active drug showed clear improvements in memory, language, awareness of time and place, and a more complex process called “praxis”, which means having an idea and then actually putting it into practice.

More: continued here

Are You Interested in Starting Your Own Health Related Home Based Business? Please Click Here to Find Out How!

For the first time, new research demonstrates that curbing harmful antioxidant processes in the brain’s vasculature can reverse some of the cognitive decline associated with Alzheimer’s disease. A natural enzyme of the immune system — NADPH oxidase — has been found to have toxic side effects, producing free radicals in the brains of mice.

More: continued here

Are You Interested in Starting Your Own Health Related Home Based Business? Please Click Here to Find Out How!

In a study in patients with mild-to-moderate Alzheimer’s disease (AD), the addition of Lipitor (atorvastatin calcium tablets) 80 mg to Aricept® (donepezil HCl) 10 mg showed no significant differences in cognition or global function (key measures of Alzheimer’s progression) compared to placebo plus Aricept 10 mg. Furthermore, no statistically significant differences were seen on various cognitive, behavioral and functional secondary endpoints.

More: continued here

Are You Interested in Starting Your Own Health Related Home Based Business? Please Click Here to Find Out How!

It is important that people lead a healthy lifestyle to reduce their risk of developing dementia. This research adds to the weight of evidence on drinking and smoking habits and the risk of developing dementia. Smoking, drinking heavily and having high cholesterol can all lead to an increased risk of developing this devastating condition and the risk is further increased for individuals with a particular genetic variant.

More: continued here

Are You Interested in Starting Your Own Health Related Home Based Business? Please Click Here to Find Out How!

Medivation, Inc. (NASDAQ: MDVN) has announced that Alzheimer’s patients treated with the investigational drug Dimebon™ showed improvement in the key aspects of cognitive function over a one-year period compared with placebo. The improvement occurred in not only memory and language, but also in more complex functions such as awareness of time and place, and praxis - the process of getting an idea and initiating and completing a new motor task.

More: continued here

Are You Interested in Starting Your Own Health Related Home Based Business? Please Click Here to Find Out How!

New York-Presbyterian Hospital/Weill Cornell Medical Center and Baxter International Inc. (NYSE: BAX) announced results of a six-month, placebo-controlled Phase II study of 24 patients treated with GAMMAGARD S/D and GAMMAGARD LIQUID [Immune Globulin Intravenous (IGIV)] for the treatment of mild-to-moderate Alzheimer’s disease today at the American Academy of Neurology (AAN) annual meeting in Chicago.

More: continued here